Know Cancer

or
forgot password

Phase II Study of the Effects of Ginger Root Extract on Eicosanoids in Colon Mucosa in People at Normal and Increased Risk for Colorectal Cancer


Phase 2
18 Years
N/A
Not Enrolling
Both
Colorectal Cancer

Thank you

Trial Information

Phase II Study of the Effects of Ginger Root Extract on Eicosanoids in Colon Mucosa in People at Normal and Increased Risk for Colorectal Cancer

Inclusion Criteria


Inclusion Criteria Normal Risk:

- 18 years or older and in good health as defined by an unremarkable medical history,
physical and screening blood work (chemistry screen, complete blood count) within 60
days of study entry.

- No chronic medication use was allowed and participants could not have taken aspirin
or related NSAIDs during the study or 14 days before the first dose of the study
medication.

- Participants also had to be classified as being at normal-risk for developing
colorectal cancer. Normal-risk was defined as having: no first-degree relatives with
colon cancer diagnosed before the age of 60; no personal history of colorectal cancer
and no adenomas >1 cm in size or containing carcinoma in situ

Exclusion Criteria for both Normal and Increased Risk for Colorectal Cancer:

1. a history of peptic ulcer disease, gastrointestinal bleeding from gastric or
duodenal ulcers, or gastrin secreting tumors;

2. pregnant or lactating women;

3. history of cardiovascular disease;

4. lactose intolerance;

5. or an allergy to ginger

6. a history of familial colorectal cancer syndromes;.

Inclusion Criteria Increased Risk:

- 18 years or older and in good health as defined by an unremarkable medical history,
physical and screening blood work (chemistry screen, complete blood count) within 60
days of study entry.

- No chronic medication use was allowed and participants could not have taken aspirin
or related NSAIDs during the study or 14 days before the first dose of the study
medication.

- Participants also had to be classified as being at increased-risk for developing
colorectal cancer. Increased-risk is defined as having at least one of the
following: a first-degree relatives with colon cancer diagnosed before the age of 60;
a personal history of early stage colorectal cancer and/or no adenomas >1 cm in size
or containing carcinoma in situ

Type of Study:

Interventional

Study Design:

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Prevention

Outcome Measure:

Determine changes in levels from baseline of prostaglandin E2

Outcome Time Frame:

Baseline and day 28

Safety Issue:

No

Principal Investigator

Suzanna M Zick, ND, MPH

Investigator Role:

Principal Investigator

Investigator Affiliation:

University of Michigan

Authority:

United States: Institutional Review Board

Study ID:

Ginger-01HR

NCT ID:

NCT01344538

Start Date:

April 2007

Completion Date:

December 2012

Related Keywords:

  • Colorectal Cancer
  • ginger
  • Zingiber officinale
  • Cancer Risk Reductive
  • Eicosanoids
  • Colorectal Cancer
  • Inflammation
  • Colorectal Neoplasms

Name

Location

University of Michigan Ann Arbor, Michigan  48109-0624